MCI Inc.

• PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).
• If you purchased Anavex stock during the Class Period and sustained a loss on your investment in these shares, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
• You may contact the firm about this matter by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
• The complaint alleges Anavex falsely portrayed to investors its research program and the likelihood that its Rett syndrome trials would be successful.

• Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
• On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
• Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
• Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

• Revenue growth was driven by a 52% increase in LDD revenue and a 98% increase in LAL revenue compared to the fourth quarter of 2022.
• Gross profit for the fourth quarter of 2023 was $17.7 million or 62% of revenue, an increase of $10.2 million or 138% compared to gross profit of $7.4 million or 46% of revenue for the fourth quarter of 2022.
• Total operating expenses for the fourth quarter of 2023 were $28.5 million, a 27% increase from $22.4 million in the fourth quarter of 2022, reflecting the company’s ongoing investments to grow its LDD installed base and support increased LAL procedure volumes.
• On Wednesday, February 28, 2024, at 1:30 p.m. Pacific Time, the company will host a conference call to discuss its fourth quarter 2023 and full year 2023 financial results.

• Maybe the Tesla directors who agreed to pay Elon Musk US$56 billion were just feeling generous.
• Or maybe, as the judge who cancelled this “unfathomable” deal suggested, they really were “starry eyed” and swayed by Musk’s “superstar appeal”.
• Certainly Musk – and his style of leadership – seems to be constantly in the spotlight.
• My research suggests that charismatic leadership seems to be enjoying a renaissance, having fallen out of fashion over the past two decades.

The return of charisma?

• The CEOs of the most famous global companies ten years ago, such as ExxonMobil and Walmart, were not household names.
• But today, the bosses of corporations such as Meta, Amazon and Tesla are world famous.
• The search for Khurana’s “saviour” figures seems to offer a simple escape route from worries over climate change, war and economic turbulence.

Furthermore, in a world increasingly reliant on algorithms, business has become somewhat dehumanised. People may be yearning for leadership with a (super)human face.

A more crowded stage

• If the charismatic leader is making a comeback, it is a comeback on a more crowded stage.
• They may be popular in certain circles, but so too is the leader as a champion of diversity, or ethics, or human relationships.
• So, perhaps the big question is how we can best moderate the enormous concentration of power accumulated by some charismatic leaders.

Sverre Spoelstra does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.